| abstract |
An anti-Siglec15 antibody, an antigen-binding fragment thereof, the medical use thereof, a chimeric antibody and a humanized antibody comprising the CDR region of the antibody, a pharmaceutical composition comprising the anti-Siglec15 antibody and the antigen-binding fragment thereof, and the use of the antibody in the preparation of a drug for treating diseases or conditions. |